Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
25.15
+0.70 (2.86%)
Mar 4, 2026, 12:44 PM EST - Market open

Zymeworks Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
105.9776.376.01412.4826.68
Revenue Growth (YoY)
38.87%0.38%-81.57%1446.03%-31.50%
Gross Profit
105.9776.376.01412.4826.68
Selling, General & Admin
61.5161.5170.4573.3642.56
Research & Development
137134.62143.62208.6199.75
Other Operating Expenses
-17.29---
Total Operating Expenses
198.51213.41214.07281.95242.31
Operating Income
-92.55-137.11-138.05130.53-215.63
Interest Income
13.3519.9419.713.61.97
Other Non-Operating Income (Expense)
-0.560.56-0.891.111.31
Total Non-Operating Income (Expense)
12.820.518.814.713.27
Pretax Income
-79.75-116.61-119.24135.23-212.36
Provision for Income Taxes
1.386.08-0.5710.89-0.52
Net Income
-81.13-122.7-118.67124.34-211.84
Net Income to Common
-81.13-122.7-118.67124.34-211.84
Shares Outstanding (Basic)
7576696552
Shares Outstanding (Diluted)
7576696552
Shares Change (YoY)
-0.61%10.19%5.54%25.16%3.47%
EPS (Basic)
-1.08-1.62-1.721.91-4.11
EPS (Diluted)
-1.08-1.62-1.721.90-4.61
Free Cash Flow
-34.53-112.05-120.8135.96-204.86
Free Cash Flow Per Share
-0.46-1.48-1.752.08-3.93
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-87.34%-179.69%-181.62%31.64%-808.22%
Profit Margin
-76.56%-160.80%-156.13%30.14%-794.01%
FCF Margin
-32.58%-146.85%-158.92%32.96%-767.82%
EBITDA
-84.82-128.43-127.89137.76-209.1
EBITDA Margin
-80.05%-168.31%-168.25%33.40%-783.74%
EBIT
-92.55-137.11-138.05130.53-215.63
EBIT Margin
-87.34%-179.69%-181.62%31.64%-808.22%
Effective Tax Rate
-1.73%-5.22%0.48%8.05%0.24%
Updated Mar 2, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q